Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-06

Clinical Trial Update: Natrunix Versus Methotrexate in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing Natrunix to methotrexate in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Natrunix

Snippet

Sponsor: XBiotech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN